Development
Ultralife Corporation
ULBI
$7.78
$0.0851.11%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -60.18% | 1,065.32% | -54.46% | 6.28% | -146.68% |
| Total Depreciation and Amortization | 0.00% | 1.65% | -6.63% | -8.21% | -0.79% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 45.45% | 37.50% | -20.00% |
| Total Other Non-Cash Items | -67.99% | 700.00% | -328.57% | 57.58% | -163.77% |
| Change in Net Operating Assets | 8.66% | -128.31% | -198.49% | 249.79% | 41.58% |
| Cash from Operations | -150.77% | 228.28% | -153.24% | 700.47% | -139.89% |
| Capital Expenditure | -3.49% | -3.82% | -75.62% | 65.10% | -278.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.49% | -3.82% | -75.62% | 65.10% | -278.97% |
| Total Debt Issued | -2.50% | -13.04% | -- | -100.00% | 1,700.00% |
| Total Debt Repaid | 0.00% | 0.00% | 66.67% | -200.00% | 0.00% |
| Issuance of Common Stock | 1,479.03% | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 55.51% | -13.22% | 214.00% | -221.18% | 403.73% |
| Foreign Exchange rate Adjustments | 110.08% | -158.70% | -15.00% | 68.75% | -11.30% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.99% | 2,579.63% | -116.31% | 1,150.79% | 93.27% |